Age-related macular degeneration (AMD) is the leading cause of visual impairment in people over 50. Improving treatment options for patients is a major challenge for research. In a new study, a team of researchers from Inserm, CNRS and Sorbonne University at the Institut de la Vision[1] in Paris…
Read the articleInstitut de la Vision One of the world's leading research center for vision diseases
The Institut de la Vision tackles both major public health issues in ophthalmology and rarer diseases to bring hope to all those affected by visual impairment. It brings together researchers, doctors, patients and partners to accelerate scientific research into innovative new treatments for the visually impaired.
